Cited 0 times in 
Cited 0 times in 
Evaluating the Efficacy of Immune Checkpoint Inhibitors in Elderly Patients: A Systematic Review and Meta-analysis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Han-sang | - |
| dc.date.accessioned | 2025-02-03T08:01:18Z | - |
| dc.date.available | 2025-02-03T08:01:18Z | - |
| dc.date.created | 2026-01-22 | - |
| dc.date.issued | 2025-10 | - |
| dc.identifier.issn | 1064-3745 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/201519 | - |
| dc.description.abstract | In this chapter, we outline the steps for designing and conducting a rigorous systematic review and meta-analysis, focusing on the efficacy of immune checkpoint inhibitors (ICIs) in elderly patients. ICIs have improved survival rates in advanced cancers, yet their effectiveness in older populations remains unclear. We detail the essential processes involved in both systematic reviews and meta-analyses. We can evaluate the efficacy of ICIs in elderly patients with advanced cancer, examining outcomes such as overall survival and progression-free survival. © The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2025. | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Humana Press | - |
| dc.relation.isPartOf | Methods in Molecular Biology | - |
| dc.relation.isPartOf | Methods in Molecular Biology (Clifton, N.J.) | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.subject.MESH | Aged | - |
| dc.subject.MESH | Humans | - |
| dc.subject.MESH | Immune Checkpoint Inhibitors* / therapeutic use | - |
| dc.subject.MESH | Immunotherapy / methods | - |
| dc.subject.MESH | Neoplasms* / drug therapy | - |
| dc.subject.MESH | Neoplasms* / immunology | - |
| dc.subject.MESH | Neoplasms* / mortality | - |
| dc.subject.MESH | Progression-Free Survival | - |
| dc.subject.MESH | Treatment Outcome | - |
| dc.title | Evaluating the Efficacy of Immune Checkpoint Inhibitors in Elderly Patients: A Systematic Review and Meta-analysis | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Kim, Han-sang | - |
| dc.identifier.doi | 10.1007/978-1-0716-4128-6_11 | - |
| dc.relation.journalcode | J02226 | - |
| dc.identifier.eissn | 1940-6029 | - |
| dc.identifier.pmid | 39348060 | - |
| dc.identifier.url | https://link.springer.com/protocol/10.1007/978-1-0716-4128-6_11 | - |
| dc.subject.keyword | Age | - |
| dc.subject.keyword | Elderly | - |
| dc.subject.keyword | Immune checkpoint inhibitor | - |
| dc.subject.keyword | Immunosenescence | - |
| dc.subject.keyword | Immunotherapy | - |
| dc.subject.keyword | Meta-analysis | - |
| dc.subject.keyword | Systematic review | - |
| dc.subject.keyword | Systemic reviews | - |
| dc.contributor.alternativeName | Kim, Han Sang | - |
| dc.contributor.affiliatedAuthor | Kim, Han-sang | - |
| dc.identifier.scopusid | 2-s2.0-85205336361 | - |
| dc.citation.volume | 2857 | - |
| dc.citation.startPage | 117 | - |
| dc.citation.endPage | 125 | - |
| dc.identifier.bibliographicCitation | Methods in Molecular Biology, Vol.2857 : 117-125, 2025-10 | - |
| dc.identifier.rimsid | 91246 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Age | - |
| dc.subject.keywordAuthor | Elderly | - |
| dc.subject.keywordAuthor | Immune checkpoint inhibitor | - |
| dc.subject.keywordAuthor | Immunosenescence | - |
| dc.subject.keywordAuthor | Immunotherapy | - |
| dc.subject.keywordAuthor | Meta-analysis | - |
| dc.subject.keywordAuthor | Systematic review | - |
| dc.subject.keywordAuthor | Systemic reviews | - |
| dc.type.docType | Book chapter | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.